tradingkey.logo

CVS rises after UBS upgrades on healthcare benefits recovery

ReutersAug 18, 2025 12:54 PM

Brokerage UBS upgrades healthcare conglomerate CVS Health CVS.N to "buy" from "neutral," raising PT to $79 from $67

New PT represents a ~13.2% upside to the stock's last close

Shares of CVS up 2.2% at $70.1 premarket

UBS says CVS has managed its Medicare Advantage plans well, giving the brokerage more confidence in its future performance

UBS believes CVS will reduce its debt by late 2026, allowing for more share buybacks and further earnings growth

UBS says it does not expect any major negative changes from drug pricing rules or its Star ratings in the near term

As of last close, CVS stock up 52.8% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI